We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-4 of 4

FDA is cracking down on illegal Internet pharmacies

  • Fox Rothschild LLP
  • -
  • USA
  • -
  • October 17 2012

As a participant in the operation Pangea V, a global cooperative for combating the online sale and distribution of potentially counterfeit and illegal medical products, FDA announced that it has taken action against more than 4,100 Internet pharmacies

Enzyte enhances only the jail exposure of the charlatans who promoted it

  • Fox Rothschild LLP
  • -
  • USA
  • -
  • January 17 2011

Over the last ten years, television viewers have been inundated with commercials starring "Smiling Bob," whose enthusiastic mien, we learn, stems from his happy experiences with Enzyte, a male performance-enhancing product

Physicians forewarned - the impact of medical device fraud on physicians' practices

  • Fox Rothschild LLP
  • -
  • USA
  • -
  • February 3 2012

A recent U.S. Department of Justice (DOJ) settlement with a medical device manufacturer highlights the need for physicians to pay close attention to their dealings with medical device companies

Game changing off-label marketing decision has implications for related securities lawsuits

  • Fox Rothschild LLP
  • -
  • USA
  • -
  • December 5 2012

I previously wrote about how the Food and Drug Administration and Department of Justice used the responsible corporate officer doctrine to charge former Purdue Pharma executives and in-house counsel with criminal liability and career-ending debarment for “off-label” drug marketing, even though the charged parties did not personally participate in the conduct or even know about it